NCT01509625View on ClinicalTrials.gov

Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)

CompletedOBSERVATIONAL
Enrollment

272

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

March 31, 2014

Conditions
Malignant Neoplasm of Breast Stage IV
Interventions
DRUG

Fulvestrant

It is an observacional retrospective study to asses the results of the administration of fulvestrant in the routine clinical practice.

Trial Locations (7)

Unknown

Hospital San Cecilio, Granada

Hospital Universitario Virgen de las Nieves, Granada

Hospital Torrecardenas Almería, Almería

Complejo Hospitalario de Jaén, Jaén

Hospital SAS Jeréz de la Frontera, Jeréz de La Frontera

Hospital Costa del Sol, Marbella

Hospital Carlos Hayas, Málaga

All Listed Sponsors
lead

Isabel Blancas

OTHER

NCT01509625 - Retrospective Study Assessment Treatment Response Faslodex®( 500 mg) | Biotech Hunter | Biotech Hunter